This HTML5 document contains 122 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n9	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q33331105

rdf:type

wikibase:Item

schema:description

2000年论文 artículu científicu espublizáu en 2000 научни чланак מאמר מדעי wissenschaftlicher Artikel article scientific tieteellinen artikkeli 2000年論文 tudományos cikk videnskabelig artikel (udgivet 2000) artigo científico (publicado na 2000) vědecký článek 2000 թուականի Յունուարին հրատարակուած գիտական յօդուած articol științific 2000年論文 2000年论文 artigo científico naučni članak επιστημονικό άρθρο artículo científico publicado en 2000 article scientifique (publié 2000) artikull shkencor artigo científico (publicado na 2000) artykuł naukowy مقالهٔ علمی научна статия vetenskaplig artikel 2000年論文 наукова стаття, опублікована в січні 2000 teaduslik artikkel 2000年论文 2000 թվականի հունվարին հրատարակված գիտական հոդված vedecký článok 2000年論文 سائنسی مضمون wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch vitenskapelig artikkel 2000年论文 bilimsel makale wetenschappelijk artikel bài báo khoa học სამეცნიერო სტატია artikulong pang-agham научни чланак научная статья 2000년 논문 articolo scientifico vitskapeleg artikkel 2000年論文 บทความทางวิทยาศาสตร์ article científic 2000年の論文 мақолаи илмӣ mokslinis straipsnis мақолаи илмӣ 2000年论文 2000年论文 scientific article ২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية scienca artikolo 2000 nî lūn-bûn

p:P577

wds:Q33331105-1BDE1D85-DBD8-4E31-A977-675AF26B57EE

wdt:P577

2000-01-01T00:00:00Z

p:P407

wds:Q33331105-DD6C7DEB-16C1-4A5B-9CFE-2FFD17841855

wdt:P407

wd:Q1860

p:P2093

wds:Q33331105-22AFF0C0-3AB9-451B-A88A-FC497217ADE8 wds:Q33331105-D6CA439D-E580-42A1-A282-C9F1F3249C91 wds:Q33331105-D01D5F75-4B39-4B2D-9A5C-F5B236671538 wds:Q33331105-AB9FBED6-8F10-47A9-BD54-4040A90A3DE6 wds:Q33331105-8C6CCA3F-3893-46C9-86B2-0822D10A0C52 wds:Q33331105-E5DBCDC6-ED3D-495D-88A3-F096FED4BFA6 wds:Q33331105-00BF46E7-BFED-4C43-8A90-7AE60E160DA6

wdt:P2093

M F Brady T H Niemann G Sutton P S Braly R D Alvarez S L Lentz P R Kucera

rdfs:label

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

skos:prefLabel

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

schema:name

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

p:P50

wds:Q33331105-71AEDE24-A4DF-4E3F-A0CD-889A0706995C wds:Q33331105-fcc4f827-4368-57ac-4fd4-da68f085ad72

wdt:P50

wd:Q30512486 wd:Q105453590

p:P1476

wds:Q33331105-92FBC76B-7289-404E-9A6E-8F149EFC6DAD

wdt:P1476

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

p:P304

wds:Q33331105-11B0BF1C-AB7A-4C4F-9060-9B438DC0AD9D

wdt:P304

106-115

p:P31

wds:Q33331105-02A9FEF8-1825-4827-8BCC-10182ED9C9F8

wdt:P31

wd:Q13442814

p:P921

wds:Q33331105-526269BE-816B-4BEC-9208-440C0BD0A411 wds:Q33331105-5FDB09ED-40C4-4919-AA5E-6AC2A3EF6639 wds:Q33331105-21783D9F-3F6B-4783-A823-910DF5083FF5 wds:Q33331105-26798A2E-2B1C-4FA0-9589-C6B859A08892 wds:Q33331105-20325BEA-34AB-4C01-988B-B09C821EF57F

wdt:P921

wd:Q5625186 wd:Q412415 wd:Q423762 wd:Q181600 wd:Q172341

p:P698

wds:Q33331105-2BA4CD2C-6955-427C-8314-380D6E72F4A1

wdtn:P698

n12:10623700

wdt:P698

10623700

p:P1433

wds:Q33331105-6AAF711B-307B-434A-9589-83D20CEEDABB

wdt:P1433

wd:Q400292

p:P433

wds:Q33331105-FD1F8161-CF0E-4F2C-9DAE-D782416F6B14

p:P478

wds:Q33331105-342595D5-7927-4983-A342-C543E62AB66A

wdt:P433

1

wdt:P478

18

p:P356

wds:Q33331105-B789F12F-4106-4EDA-95C7-74B4EA413758

wdtn:P356

n9:JCO.2000.18.1.106

wdt:P356

10.1200/JCO.2000.18.1.106